ArticleFrontiers in chemistry2026
A structure and function-based complete mutational map of human hemoglobin using AI.
Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A structure and function-based complete mutational map of human hemoglobin using AI.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemoglobin (Hb), a well-characterized protein central to oxygen transport and molecular medicine, serves as a model for studying how sequence variations influence protein structure and function. Its precise activity depends on tightly regulated structural dynamics, which can be disrupted by mutations that give rise to structural hemoglobinopathies, including sickle cell disease, unstable hemoglobins, methemoglobins, and hemoglobins with altered oxygen affinity, each associated with distinct functional and clinical consequences. Among genetic variants, missense mutations are the most widely studied in clinical settings. Accurately predicting their clinical impact remains challenging, requiring integration of evolutionary, biochemical, and structural data. While broad deep learning models like AlphaMissense show promise, they often lack interpretability and protein-specific precision. This motivates the development of focused models that leverage detailed knowledge of individual proteins, like hemoglobin, to improve both predictive power and mechanistic understanding. In this work, we conducted a comprehensive analysis of all known and potential human adult hemoglobin (HbA) variants, guided by the hypothesis that a deep understanding of the sequence-structure-function relationship in Hb can yield interpretable and predictive insights into the functional and clinical consequences of single amino acid substitutions. We curated an updated dataset of HbA variants annotated with their clinical classifications, Benign, Pathogenic, or of Uncertain Significance (VUS), and systematically mapped each to a range of features, including structural location and classification, predicted impact on folding stability, and evolutionary conservation. Using this data, we developed a pathogenicity prediction model and benchmarked it against AlphaMissense, demonstrating strong and complementary performance. Additionally, we generated a complete mutational landscape of all possible single amino acid substitutions (SAS) in HbA, providing a resource for future clinical interpretation. Our findings provide insight into the molecular basis for variant effects in HbA and highlight the utility of combining structure-informed features with Machine Learning (ML) for variant interpretation. Moreover, our results offer a framework for evaluating the portability and interpretability of variant effect predictors across structurally dynamic systems, with implications in the improvement of variant classification in other protein families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.